GP
ANAC

GLG Partners’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

GLG Partners’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-147,125
Closed -$3.6M – 542
2014
Q3 		$3.6M Sell
147,125
-159,527
-52% -$3.24M 0.08% 249
2014
Q2 		$5.44M Buy
306,652
+36,652
+14% +$590K 0.13% 176
2014
Q1 		$5.4M Buy
+270,000
New +$5.24M 0.11% 189

Other funds holding ANAC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GLG Partners's ANAC Position: Q4 2014 in Review

GLG Partners sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2014, closing a stake of 147,125 shares — an estimated $3.6M sold.

GLG Partners first reported a position in ANAC in Q1 2014 and held it in 3 quarters. The position peaked at $5.44M in Q2 2014. 147 funds tracked by Wall St. Rank hold ANAC as of Q4 2014.

  • GLG Partners reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2014 after selling out during the quarter.
  • GLG Partners sold 147,125 ANACOR PHARMACEUTICALS INC COM shares in Q4 2014, an estimated $3.6M.
  • GLG Partners first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 3 quarters.
  • GLG Partners's ANACOR PHARMACEUTICALS INC COM position peaked at $5.44M in Q2 2014.
  • 147 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2014.

Based on GLG Partners's 13F filing for Q4 2014, filed 17 Feb 2015.